Phytopharmaceuticals in India: A case for perpetual ‘New Drug’-style regulation over ASU-style… Milind Vinayak Sathe May 4, 2026 Introduction Phytopharmaceuticals in India: Bridging Tradition, Science and “New Drug”-Style Regulation Setting the stage…
Shilpa Medicare IBRUSHIL for treatment of leukaemia EP News Bureau May 28, 2020 Earlier it had launched Lenvatinib ‘LENSHIL and Dasatinib ‘DASASHIL’ in the India market
